Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018089752) METHODS OF USING HUMAN MESENCHYMAL STEM CELLS TO EFFECT CELLULAR AND HUMORAL IMMUNITY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/089752 International Application No.: PCT/US2017/061031
Publication Date: 17.05.2018 International Filing Date: 10.11.2017
IPC:
A61K 35/28 (2015.01) ,A61P 9/00 (2006.01) ,A61P 39/00 (2006.01) ,G01N 33/15 (2006.01)
[IPC code unknown for A61K 35/28][IPC code unknown for A61P 9][IPC code unknown for A61P 39][IPC code unknown for G01N 33/15]
Applicants:
LONGEVERON LLC [US/US]; 1951 NW 7th Avenue Suite 300 Miami, Florida 33136, US
Inventors:
HARE, Joshua M.; US
LANDIN, Ana Marie; US
Agent:
HANSEN, Christine M.; US
MARKOWSKI, Mythili; US
Priority Data:
62/421,04811.11.2016US
Title (EN) METHODS OF USING HUMAN MESENCHYMAL STEM CELLS TO EFFECT CELLULAR AND HUMORAL IMMUNITY
(FR) PROCÉDÉS D'UTILISATION DE CELLULES SOUCHES MÉSENCHYMATEUSES HUMAINES POUR INDUIRE UNE IMMUNITÉ CELLULAIRE ET HUMORALE
Abstract:
(EN) The present invention provides a method of treating subjects with non-ischemic dilated cardiomyopathy by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells. The present invention also provides a method of treating subjects with symptoms of aging frailty by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells.
(FR) La présente invention concerne un procédé de traitement de sujets atteints d'une cardiomyopathie dilatée non ischémique par l'administration d'une quantité thérapeutiquement efficace d'une population isolée de cellules souches mésenchymateuses humaines allogéniques. La présente invention concerne également un procédé de traitement de sujets présentant des symptômes de fragilité liée à l'âge par l'administration d'une quantité thérapeutiquement efficace d'une population isolée de cellules souches mésenchymateuses humaines allogéniques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)